Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
Supplemental Guidance on Identifying Pickup Copy
-
Hello @Manufacturer and @Agency
Please see additional guidance on submission requirements documents created in collaboration with bMod Communications. This document provides supplemental guidance on how to properly identify pickup copy to get the most out of ARO timelines and reduced fees for pieces with large percentages of pickup.
Alternative ways to meet the requirements are showcased in the examples to help you integrate these new practices into your workflows.
